주메뉴
- 나의 진료정보
- 진료안내
-
병원소개
찾아오시는길
분당서울대학교병원에 찾아오시는 길입니다.
우)13620, 경기도 성남시 분당구 구미로173번길 82
대중교통 이용-
- 미금역에서 버스 이용시
- 미금역 3번 출구 → 마을버스(7번, 7-1번), 8446번 버스 탑승 → 분당서울대학교병원
- 미금역 2번 출구 → 51번 버스 탑승 → 분당서울대학교병원
- 미금역 8번 출구 → 마을버스(19번), 380번 버스 탑승 → 분당서울대학교병원
-
- 오리역에서 버스 이용시
- 오리역 7번 출구 → 10m 앞 마을버스(19번) 탑승 → 분당서울대학교병원
-
- 정자역에서 버스 이용시
- 정자역 3번 출구 → 마을버스(19번, 111번), 380번, 8446번 버스 탑승 → 분당서울대학교병원
-
- 헬스케어혁신파크(상행) 하차시
- 분당서울대학교병원 방향 탄천길로 도보 15분
자동차 이용-
- 판교 IC 방면
- 판교 IC → 분당방향으로 직진 → 서현로 → 분당구청 방향으로 우회전 → 분당구청 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 성수대교 방면
- 성수대교 → 구룡터널 → 분당내곡간 고속화도로(약 15분 직진) → 분당 도착해서 직진 → 분당구청 → 수내역 방향으로 우회전 → 정자역 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 청담대교 방면
- 청담대교 → 분당수서간 고속화도로(약 25분 직진) → 초림지하차도 → 정자지하차도(2번째 지하도) 지난 후 우측차선으로 빠짐 → 미금역 방향 → 미금역 방향으로 좌회전 → 돌마교사거리에서 우회전 → 700m정도 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
- 수원 IC 방면
- 수원 IC → 신갈오거리 → 신갈중학교 앞 → 구성삼거리 → 마북삼거리 → 보정교차로 → 죽전사거리 → 오리역 → 낙생교 지나자마자 우회전 → 미금교 → 분당서울대학교병원
-
- 수서역 SRT 방면
- 밤고개로(약 5분 직진) → 분당내곡간 고속화도로(약 10분 직진) → 분당 도착해서 직진 → 분당구청 → 수내역 방향으로 우회전 → 정자역 → 분당정보산업고교에서 좌회전 → 돌마교사거리에서 직진 → 아름다운 교회에서 좌회전 → 미금교 → 분당서울대학교병원
-
-
공지사항
공지사항
분당서울대학교병원의 공지사항을 알려드립니다.
-
건강정보
건강정보
다양하고 유익한 건강상식을 제공해 드립니다.
-
- 40만 개의 난포로 생명 탄생을 이끄는 난소 바로알기!
- 여성의 몸은 생명을 잉태하기 위한 신비한 신체 기관을 갖추고 있다. 이런 여성 생식기관 중 중요한 역할을 담당하는 것이 바로 자궁과 난소다. 자궁은 길이 약 8~9㎝, 폭 6㎝, 두께 4㎝, 무게 50㎎ 정도의 작은 기관이다. 하지만 임신 후에는 20배가량 늘어나며, 용적도 임신 전보다 500배로 커진다. 이런 자궁 뒤쪽으로는 2개의 난소가 좌우에 각각 1개씩 자리 잡고 있다. 난자를 보관하고 배란하는 난소 난소는 작은 살구나 아몬드 모양의 타원형 구조를 띤다. 신생아나 소아기에는 작고 긴 모양이다가 사춘기에 이르러 점 차 커지고, 폐경 후에는 다시 작아진다. 좌우 나팔관 아랫부분에 1개씩 존재한다. 난소는 피질(겉)과 수질(속)로 구성된 다. 피질은 다양한 크기의 난포(여포)를 포함하고 수질은 섬유근육 조직과 혈관으로 되어있다. 난포는 주머니 모양의 세 포 집합체로 난자를 포함하고 있으며 난자의 배란 후 황체로 변화한다. 난소의 크기는 다양하지만, 정상 난소의 경우 일 반적으로 길이 약 3~5㎝, 무게 7~10g 정도에 해당한다. 표면은 난소간막이라는 복막에 둘러싸여 있다. 여성은 보통 미성숙 난자인 원시난포를 200만 개가량 가지고 태어난다. 이중 약 40만 개 정도가 사춘기까지 생존해 난 포로 자라난다. 월경주기마다 여러 개의 난포가 함께 동원되지만 최종적으로 한 개의 난포만 성숙하여 배란된다. 폐경 기를 맞아 생식능력을 잃으면 남아 있던 난포도 모두 퇴화하므로, 여성은 평생의 가임기간 동안 400여 개의 난포만을 성숙시키는 셈이다. 난소는 난자를 만들고 보관하며 성숙시켜 배란(방출)이 이루어지도록 하는 기관이다. 이때 배란된 난자는 나팔관을 통 해 자궁으로 이동한다. 난소의 또 다른 기능은 호르몬 생성이다. 에스트로겐, 프로게스테론 같은 여성 호르몬과 소량의 테스토스테론 같은 남성 호르몬을 분비한다. 이들 호르몬의 분비는 시상하부, 뇌하수체에서 분비되는 자극 호르몬들과 상호작용을 통해 조절된다. 난소의 기능은 경구피임약, 생식샘자극호르몬방출 호르몬 유사체(Gonadotropin Releasing Hormone (GnRH) Analogue), 배란 유도제, 항암 치료 등의 약제, 스트레스, 영양상태 등 외부의 영향에 따라 변화할 수 있다. 난소의 크기 도 이에 영향을 받을 수 있다. 난소 건강에 대한 궁금증 풀이 ➊ 난소 나이는 신체 나이와일치하지 않는다? 요즘에는 항뮬러관 호르몬(Anti-Müllerian Hormone, AMH) 검사를 통해 간단한 채혈 만으로 ‘난소 나이’를 측정할 수 있다. 월경주 기에 상관없이 검사할 수 있다. 미성숙 난포에 서 분비되는 호르몬 수치가 높으면 난소 안에 배란될 난포들이 많다는 뜻이며, 그 수치가 낮 으면 배란될 난포가 적다고 볼 수 있다. 난소 의 나이는 신체 나이와 꼭 일치하지 않는다. 같은 연령대의 여성이라도 AMH 수치가 다르 고 원시난포의 경우는 100배까지 차이 나는 경우도 있다. ➋ 난소 건강이 안 좋을 때전조증상이 있다? 난소 기능 저하를 미리 가늠할 수 있는 증상 은 없다. 대부분 월경주기 및 양에 변화가 생 겨 병원을 찾았다가 우연히 난소 기능의 저하 를 발견하곤 한다. 아예 아무런 특이 증상이 없는 환자도 많다. 따라서 임신을 계획하고 있 는 여성이라면, 난소 기능 검사를 통해 본인의 상태를 정확히 파악해 보는 것이 좋다. ➌ 난자 냉동이 필요할까? 최근 들어 난자를 냉동하는 이들이 늘고 있다. 난소 질환이 있는 경우, 난소 기능이 저하된 경우, 아직 미혼으로 당장 결혼 및 출산 계획 이 없는 경우 등은 난자 냉동을 고려해 볼 수 있다. 단, 나이가 많아도 자연임신이 가능하 고, 시술로도 임신이 가능하므로 반드시 먼저 산부인과 전문의와 상담해야 한다 난소 관련 질환은? ‘난소낭종(Ovarian Cyst, Ovarian Cystic Tumor)’은 난소에 발생하는 종양으로, 기능성(생리적) 낭종과 양성 난소 종양 (혹)을 통칭하는 개념이다. 대개 크지 않고 양성이며 암이 아닌 경우가 대부분이다. 기능성 낭종은 흔히 물혹이라고도 불리는데 내부가 액상 성분으로 차 있기 때문이다. 기능성 낭종은 청소년기와 가임기 연령의 배란 과정에서 흔히 발생 할 수 있다. 8㎝를 초과하는 경우는 드물며 보통 수주에서 수개월 사이에 저절로 없어진다. 하복부 통증, 요통, 잦은 소 변, 복부 팽만감, 배변 장애 등이 나타날 수 있으나 낭종이 꼬일 경우엔 심한 복통이 동반되기도 한다. 하지만 무증상인 경우가 대부분이라 골반 진찰 시 만져지거나 골반 초음파 검사 시 확인 되는 경우가 많다. 필요에 따라 CT나 MRI 등 추 가 검사를 시행할 수 있다. 기능성 낭종이라도 종류에 따라 배란이나 임신에 영향을 주어 불규칙한 생리나 난임을 초래 할 수 있다. 난소낭종이 자연적으로 사라지지 않고 지속해 관찰될 경우는 치료가 필요하다. 치료는 증상의 유무와 환자의 연령, 종 양의 크기, 악성 가능성 등 여러 요소를 고려해 판단하게 된다. 젊은 연령층에서 발생하는 작은 기능성 낭종은 주기적인 관찰만으로도 충분하다. 종양이 갑자기 커지거나 악성이 의심되는 경우는 수술을 통해 제거해야 한다. 특히 폐경기가 지난 여성, 가족이나 본인이 유방암 또는 자궁내막암, 난소암 등을 앓았던 경험이 있거나 종괴가 점점 커지는 경우엔 적 극적으로 수술을 고려해야 한다. ‘다낭난소증후군(Polycystic Ovary Syndrome)’’은 난소에서 배란이 잘 이뤄지지 않아 발생한다. 월경 불순과 난임이 유 발될 수 있고 이외에 다모증, 여드름 등이 동반될 수 있다. 장기적으로는 대사증후군과도 연관된다. 가임기 여성에게서 흔하게 나타나며 유병률은 6~15% 정도다. 아직 명확한 발병 원인이 밝혀지지 않았으나 시상하부-뇌하수체-난소의 호 르몬 불균형, 인슐린 저항성, 남성 호르몬 과다분비 등 여러 가지 요인이 제시되고 있다. 다낭난소증후군 환자는 난소에서 여성 호르몬인 에스트로겐은 정상 분비되지만, 배란이 되지 않아 황체호르몬이 생성 되지 않는다. 황체호르몬은 자궁 내막이 과도하게 증식하는 것을 막아주는데, 다낭난소증후군 환자는 이 황체호르몬이 생성되지 않으므로 자궁 내막이 과도하게 증식하고 자궁내막암 발생도 증가한다. 실제로 다낭난소증후군 환자에서 자 궁내막암 위험이 3~6배가량 높은 것으로 보고된다. 또 다낭난소증후군 환자의 50% 내외에서 인슐린 저항성이 발견되 는데, 이에 따라 40세 이전에 제2형 당뇨병이 생길 수 있다. 다낭난소증후군의 진단 기준은 성인과 청소년기가 다르다. 성인에서는 △희발 월경 혹은 무월경 △임상적 남성 호르몬 과다 증상(다모증, 여드름, 탈모) 또는 혈액검사로 확인된 남성 호르몬 수치 상승 △질식 초음파에서 확인된 다낭 난소 소 견(경우에 따라 초음파 대신 항뮬러관 호르몬 수치로 대체 가능) 이 세 가지 중 두 가지 이상에 해당하면 된다. 하지만 청소년 기에서는 조금 더 신중할 필요가 있다. 초음파 검사를 제외한 두 가지 항목으로 평가를 하고, 진단 기준에 딱 만족하지 않는 경우는 고위험군으로 간주하며 초경 8년 뒤 성인이 되어 재평가가 필요하다. 임신을 원하지 않는 환자는 주기적인 호르몬 치료를 통해 규칙적인 월경을 유도하며, 임신을 원하는 환자는 배란유도제 를 복용하게 된다. 다모증, 여드름이 동반된 환자는 남성 호르몬을 낮출 목적으로 피임약 사용을 고려할 수 있다. 무월 경이 오래 지속된 환자는 자궁내막 증식증의 위험성이 높다. 따라서 초음파 검사를 시행해 자궁내막의 두께를 확인하고 그에 맞춰 조직검사를 시행할 필요도 있다. 무엇보다 생활 습관을 개선하고 체중을 감량하는 것이 중요하다. ‘조기난소부전(Premature Ovarian Failure, Primary Ovarian Insufficiency)’은 흔히 조기 폐경이라고도 불리는 질환이 다. 40세 이전의 젊은 나이에 난소가 제 기능을 하지 않는 것을 의미한다. 조기난소부전이 발생하면 난소가 더 이상 배 란을 하지 않고 여성호르몬도 분비하지 않는다. 따라서 여성호르몬 부족과 관련된 여러 증상과 질환이 나타나게 된다. 조기난소부전의 60%는 그 원인을 알 수 없다. 염색체 이상이나 유전적인 원인은 10%에 해당한다. 수술이나 항암제, 방사선 치료 등이 원인이 될 수 있으며 자가면역질환이 있는 경우에도 영향을 미칠 수 있다. 일반적으로 40세 이하 여성 의 100명 중 1명, 30세 이하 여성의 1,000명 중 1명이 조기난소부전을 경험한다. 조기난소부전 환자는 난소 기능 저하로 인해 월경 간격이 길어지거나 월경을 아예 하지 않는 경우가 많다. 또 여성 호르 몬 감소로 인해 얼굴과 목, 어깨, 등이 후끈 달아오르는 증상(안면홍조, 열성 홍조)이 나타나고 홍조와 함께 땀을 흘리기도 한다. 이외에도 가슴 두근거림(심계 항진), 우울감, 불면증, 관절통, 잦은 소변, 요실금, 성교통, 기억력 감퇴 등이 나타날 수 있다. 난소 기능이 저하됐을 때 증상이 나타나기 때문에 난소 기능이 좋아졌다 나빠지기를 반복하는 경우 증상은 잠 시 나타날 수도 있고, 심하지 않을 수도 있다. 월경주기 변화가 여러 달 동안 있었던 경우 호르몬 검사를 시행해 조기난소부전을 진단하게 된다. 난포자극 호르몬(FSH : Follicle Stimulating Hormone)이라는 검사를 4주 이상 간격으로 2회 이상 시행해 비정상적으로 상승했을 때 진단한다. 최근에는 항뮬러관 호르몬(AMH : Anti-Müllerian Hormone)이라는 검사가 도입돼 난포자극 호르몬이 변화하기 전에 조 금 더 일찍 진단이 가능하게 됐다. 조기난소부전이 확진되면 저용량 호르몬 치료가 권고된다. 이런 증상이 2주 이상 계속된다면?난소 건강을 위해 병원 검진을 받아보자! ➊ 복부 팽만과 불편감 ➋ 극심한 복통 ➌ 복부 압박 증상 ➍ 배변 시의 불편감,배변 장애 ➎ 소화불량 ➏ 심한 생리통 ➐ 성교통 ➑ 비정상적인 출혈 올바른 생활 습관으로 전신 건강 돌봐야 난소는 여성의 신체와 건강 유지에 아주 중요한 기관 중 하나다. 안타깝게도 난소는 그 기능이 한 번 저하되면 회복이 거 의 불가능하다. 특별히 어떤 행동을 한다고 해서 난소를 더 건강하게 만들기는 어렵다. 그러나 흡연과 미세먼지, 비만, 노화, 호르몬 불균형 등이 난소 건강을 저해시킬 수 있는 것으로 알려져 있다. 따라서 교정할 수 있는 요인들은 교정하여 난소 기능이 추가적으로 저하되지 않도록 잘 관리하는 것이 필요하다. 일상에서 금연을 실천하고 미세먼지가 심할 경우 꼭 마스크를 착용해야 한다. 또 비만과 노화, 호르몬 불균형을 예방하기 위해 스트레스를 줄이고 적정 체중 유지에 신경 써야 한다. 금주와 건강한 식생활, 규칙적인 운동 등 건전한 생활 습관을 통해 전신 건강을 챙기는 것이 난소의 건강을 챙기는 길이다. 의료진 소개 산부인과 홍연희 [전문진료분야] 산부인과 : 난임, 가임력보존 (난자동결), 자궁근종, 자궁내막증, 난소낭종 , 로봇수술, 단일절개복강경수술 의료진소개 ※ 해당 기사와 사진은 분당서울대학교병원의 저작물로 임의로 복사, 수정 ,변형, 재가공하여 게시, 배포하였다면 이는 저작권자인 당사의 허가없이 2차저작물을 작성한 것으로 저작권 위반에 해당됩니다.
-
- 이른둥이 인공호흡기 떼는 골든타임, 인공지능 모델로 찾는다
- 이른둥이 인공호흡기 떼는 골든타임 인공지능 모델로 찾는다 인터뷰. 소아청소년과 정영화 교수 이른둥이(미숙아)의 인공호흡기 발관(Extubation) 시점은 빨라도, 늦어도 안 된다. 하지만 명확한 기준이 없어 의료진의 판단에 의존하는 실정이다. 이에 소아청소년과 정영화 교수 연구팀이 실시간 생체신호를 분석해 발관 성공률을 예측하는 인공지능 모델을 개발해 냈다. 이를 보조적으로 활용하면 이른둥이의 조기 발관 및 발관 성공률을 높일 수 있을 것으로 기대된다. 이른둥이에게 기도 삽관 후 인공호흡기 사용이 필요한 이유에 관해 설명을 부탁드립니다. 이른 주수에 출생한 이른둥이는 호흡기계의 미성숙으로 호흡곤란이나 잦은 무호흡이 발생할 수 있습니다. 이런 경우 정상적으로 자가호흡이 가능할 때까지 기도 삽관 후 인공 호흡기를 사용해야 합니다. 또한 미성숙한 폐로 인해 신생아중환자실에 입원하는 동안 장기간 침습적 기계환기를 포함한 여러 호흡 보조가 필요한 경우가 많습니다. 특히 주수가 짧을수록, 몸무게가 적을수록 그 빈도가 높아지죠. 최근 신생아학의 발전으로 점점 더 짧은 주수의 이른둥이들이 생존하게 되면서 생후 초기 기도 삽관이 필요한 경우가 늘고 있습니다. 마찬가지로 폐 미성숙에 의해 지속적인 기도 삽관을 유지한 채 인공호흡기 치료가 필요한 경우도 증가하고 있습니다. 이른둥이의 인공호흡기 사용 시 중요한 것은 무엇인가요? 더불어 인공호흡 장치를 제거하는 발관 시점이 왜 중요한지, 시점을 판단하는 데 어떤 어려움이 있는지 말씀해주세요. 이른둥이에게 인공호흡기는 되도록 최소한의 기간만 사용하고 발관하는 것이 좋습니다. 인공호흡기를 통해 숨 쉬는 기간이 필요 이상으로 길어지면 폐가 지속적으로 손상되기 때문입니다. 기관지폐이형성증은 미숙한 폐의 발달 과정 중 지속적인 염증과 손상으로 발생하는데, 기도 삽관 후 장기간 기계환기를 받을수록 이러한 기관지폐이형성증의 발생 위험을 높이고, 신경 발달도 지연시키는 것으로 알려져 있습니다. 따라서 가능하다면 조기에 발관하는 것이 중요합니다. 기관지폐이형성증이란? 주로 초이른둥이에게 발생하는 만성폐질환으로, 호흡곤란이 심해 장기간 인공호흡기 치료나 산소 공급을 받아야 한다. 반면 발관이 너무 이르면 잦은 저산소증과 고이산화탄소혈증이 발생해 뇌에 안 좋은 영향을 끼칠 수 있고, 발관 실패에 이를 수 있습니다. 특히 주수가 이를수록 무호흡 및 여러 다른 동반 질환으로 인해 발관에 실패할 확률이 높아지고, 발관에 실패할 경우 발생하는 혈역학적인 불안정성 역시 환자의 경과를 악화시킬 수 있습니다. 또한 잦은 발관 실패는 그 자체로 기관지폐이형성증의 발생 위험을 증가시킬 수 있어요. 따라서 발관 성공률을 최대한 높이면서, 너무 늦지도, 이르지도 않은 적절한 발관 시점을 찾는 것이 중요합니다. 하지만 아직 발관에 대한 명확한 기준이 없어 센터마다 환자의 임상 상태에 따라 의료진 개개인의 판단에 의존해 발관을 시도하고 있으며, 1,000g 미만의 이른둥이에서 발관 후 이를 유지하는 데 성공할 확률은 평균 60~73% 수준으로 보고되고 있습니다. 고이산화탄소혈증이란? 혈중에 이산화탄소가 비정상으로 증가한 상태. 호흡촉박, 호흡곤란이 발생하고 심하면 의식 상실, 전신 경련이 일어난다. 이른둥이의 발관 시점을 결정하는 데 도움을 주는 인공 지능 모델 ‘넥스트 프리딕터(NExt-Predictor)’를 개발하셨습니다. 연구 과정 및 방법, 기간 등에 관해 설명을 부탁드립니다. 분당서울대병원 신생아중환자실은 고도화된 의료정보시스템을 통해 신생아중환자실에 입원한 환자들의 생체활력징후 등의 정보가 이미 실시간으로 데이터화되고 있습니다. 이 데이터베이스를 이용하여 디지털헬스케어연구사업부 유수영 교수팀과 함께 임상 현장에서 발관 성공률을 실시간 예측할 수 있는 시스템 개발을 계획했습니다. 2003년부터 2019년까지 분당서울대병원에서 태어난 32주 미만의 이른둥이 중 기도 삽관 후 침습적 인공호흡기를 사용한 678명의 데이터를 인공지능을 통해 분석·학습하는 과정을 거쳐, 2022년 안정적인 성능을 보이는 발관 성공 예측 모델 ‘NExt-Predictor’를 개발했습니다. 또 자체 내부 데이터 베이스 및 외부 중환자실 데이터베이스(MIMIC-III)를 이용해 NExt-Predictor가 높은 성능을 보임을 검증했습니다. 발관 성공 예측 모델인 ‘NExt-Predictor’의 특장점이 무엇인지 설명해주세요. NExt-Predictor의 가장 큰 장점은 이미 모니터링하고 있는 생체활력징후 및 의무 기록 정보를 활용해 실시간 성공 예측률을 계산해준다는 것입니다. 따라서 예측을 위해 환자에게 별도의 추가 검사를 시행하거나 추가 장비를 도입할 필요가 없습니다. 또한 환자의 상태 변화를 가장 먼저 보여 주는 것이 생체활력징후이기 때문에 환자의 실시간 상태 변화를 임상 의사가 인지하기 전에 모델에 반영해 예측률을 보여준다는 장점이 있습니다. 이번 연구의 의의가 무엇인지, 해당 결과가 어떻게 활용되길 바라시는지 궁금합니다. 본 연구의 의의는 현재 임상의사 개개인의 판단만으로 이루어지는 발관 시점 결정에 추가적인 도움을 줄 수 있는 AI모델을 개발했다는 점입니다. 이 모델을 임상 판단의 보조적인 근거 수단으로 이용함으로써, 발관의 성공률을 높이는 데 기여할 수 있을 것으로 기대하고 있습니다. 이를 통해 기도 삽관을 한 이른둥이의 조기 발관 및 발관의 성공률을 높이고, 장기적으로 기관지폐이형성증의 발병률을 감소시키는 데 도움을 줄 수 있기를 바랍니다. 향후 추진할 연구나 앞으로의 목표, 계획에 대해 말씀해주십시오. 현재 개발한 AI 모델을 이용한 전향적 임상연구를 계획해 진행 중입니다. 향후 목표는 안정적인 NExt-Predictor의 성능을 확인해 생체활력징후 모니터나 EMR에 반영함으로써 실시간 임상 의사에게 정보를 제공하고 판단에 도움을 주는 것입니다. 마지막으로, <나음 플러스> 독자들에게 전하고 싶은 말씀이 있다면 부탁드립니다. 신생아학의 발전으로 초극소저체중 이른둥이의 생존율이 매우 높아졌으며, 예후 역시 많이 향상됐습니다. 현재 분당서울대병원 신생아중환자실의 의료진들은 이른둥이들이 건강하게 성장할 수 있도록 24시간 치료에 전념하고 있습니다. 앞으로도 아이들의 성장과 발달에 도움이 되도록 연구를 지속해 예후를 향상시키기 위해 노력하겠습니다. 의료진 소개 소아청소년과 정영화 [전문진료분야] 소아청소년과(신생아) : 신생아 및 미숙아, 영유아 질환 의료진소개 ※ 해당 기사와 사진은 분당서울대학교병원의 저작물로 임의로 복사, 수정, 변형, 재가공하여 게시, 배포하였다면 이는 저작권자인 당사의 허가없이 2차저작물을 작성한 것으로 저작권 위반에 해당됩니다.
-
- 바로가기
- 정보공개
- 고객의 소리
본문
페이스북
트위터
- [ 혈액종양내과 (두경부암센터) ]
- 소화기암 ,두경부암의 항암화학요법, 고형암의 임상시험
진료시간표
| 요일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 오전 |  |
|
||||
| 오후 | |
- 외래진료
- 외래클리닉
- 격주 및 순환진료
분당서울대학교병원 종양내과에 근무하고 있는 이근욱입니다. 종양내과 의사는 암환자의 상태를 포괄적으로 평가하고, 가장 적합한 치료 방법을 제시해 주며, 가장 적합한 항암화학요법을 최소한의 부작용으로 시행받을 수 있도록 도와 드리는 역할을 담당합니다. 저는 위장관에서 발생한 암종들(위암, 대장암 등) 및 두경부암의 치료를 주로 담당하고 있습니다.
최근의 암치료 방법은 급진적으로 발전하고 있습니다. 한 명의 의사가 환자의 치료를 독단적으로 결정하기에는 이미 관련분야의 지식이 너무 광범위해서 한계가 있는 실정이며, 각 분야의 의사들이 최신의 지식을 공유하여 토론한 후 가장 적합한 치료법을 정하는 ‘다학제적 치료방법 결정’이 암치료의 추세라고 할 수 있습니다. 분당서울대학교 위암, 대장암, 두경부암팀은 이미 개원 당시부터 다학제 팀(multi-disciplinary team)을 구성하여 환자분들께 최선의 치료를 제공하고 있습니다. 또한, 종양내과에서는 적합한 환자들께는 최신의 임상 시험에 참여하여 치료 받을 수 있는 기회도 제공하고 있습니다.
진료 현장에서 만나뵙는 암으로 고통받고 있는 많은 환자분들께 최고의 지식과 열정으로 암을 극복해 나가는데 도움을 드리도록 최선을 다하겠습니다.
소화기암, 두경부암의 항암화학요법
- 우리나라에서 위암은 가장 흔한 암이며, 대장암의 경우도 생활습관의 서구화에 따라 그 발생률이 급격히 증가하고 있습니다. 위암 및 대장암의 경우 완치적 절제술 후 재발방지를 위한 보조항암화학요법을 추가로 시행하는 것이 완치율을 향상시키는 것으로 확실히 증명되어 있습니다. 또한 전이성 암의 경우라 할지라도 적절한 항암화학요법을 통하여 삶의 연장 및 삶의 질을 향상시킬 수 있습니다. 특히 대장암의 경우에는 원격전이가 동반되었다 할지라도 ‘전이 절제술 (전이 병소를 제거하는 수술)’ 및 항암화학요법을 병용할 경우 상당수의 환자에서 완치를 기대할 수 있습니다.
- 두경부암의 경우, 흔하지는 않지만 항암화학요법 및 방사선치료 또는 수술을 병용할 경우 상당수에서 완치를 기대할 수 있습니다. 비록 치료 과정이 쉽지는 않으나, 경험있는 의료진의 도움을 통하여 많은 분들이 좋은 결과를 얻을 수 있는 암종입니다.
- 소화기 계통의 암과 두경부암은 외과(이비인후과), 방사선종양학과, 종양내과 및 여러 관련 의사들(소화기내과, 영상의학과, 병리학과 등)의 긴밀한 소통과 협진이 있어야만 더 좋은 치료 성적을 얻을 수 있습니다. 분당서울대병원 위암, 대장암, 두경부암팀은 조화로운 다학제적 협력을 통해서 최선의 치료를 제공해 드립니다.
고형암의 임상시험 (항암화학요법)
암치료의 방법은 매우 빨리 발전하고 있습니다. 이러한 발전은 환자들을 대상으로 한 ‘임상시험’을 통하여 이루어집니다. 특히, 새로운 항암제가 개발되어 시판되기까지 많은 임상시험의 과정을 거쳐야 합니다. 환자들께서는 임상시험을 통해서 최신의 치료방법을 접할 수 있으며 더 좋은 효과를 기대해 볼 수 있습니다. 하지만, 새로운 치료법이니만큼 부작용에 대하여 좀더 면밀한 관찰도 요구됩니다. 분당서울대학교병원 종양내과 의료진들은 임상시험에 많은 숙달된 경험을 가지고 있으며, 임상시험 수행을 통하여 새로운 암 치료법 개발에 많은 노력을 기울이고 있습니다.
직위 ●
- 분당서울대학교병원 (2020년 4월~현재) 임상시험센터장
- 서울의대 내과학 교실 (정년보장 교수) & 분당서울대학교병원 내과 (혈액종양내과) (2018년 3월~현재) 교수
학력 ●
- 2007 서울대학교 의학대학원 (분자종양학) 의학 박사
- 2004 서울대학교 의학대학원 (내과학) 의학 석사
- 1998 서울대학교 의과대학 의학 학사
경력 ●
- 2016 - 2020 분당서울대학교 병원 (2016년 7월~2020년 6월) 내과 (혈액종양내과) 혈액종양내과 분과장
- 2013 - 2018 서울의대 & 분당서울대학교 병원 내과 (혈액종양내과) 부교수
- 2012 - 2013 MD Anderson Cancer Center Department of Systems Biology 방문교수
- 2005 - 2013 분당서울대학교 병원 내과 (혈액종양내과) 임상교수
- 2004 - 2005 서울대학교 병원 내과 (혈액종양내과) 전임의
- 2000 - 2004 서울대학교 병원 내과 전공의
수상 ●
- 2017 머크-세르노 대장암 학술상 (대한종양내과학회 (KSMO))
- 2013 보령 암학술상 (대한종양내과학회 (KSMO))
- 2011 한미 우수 구연상 (대한종양내과학회 (KSMO))
- 2010 송암 학술상 (한국혈전지혈학회 (KSTH))
- 2009 보령 암학술상 (대한종양내과학회 (KSMO))
활동 ●
- 2017 대한항암요법연구회(KCSG) 위암분과 간사 (~현재)
- 대한종양내과학회 (KSMO), 대한암학회 (KCA), 대한항암요법연구회 (KCSG), 한국혈전지혈학회(KSTH), 대한내과학회 정회원
- 미국종양내과학회 (ASCO), 유럽종양내과학회 (ESMO), 미국암연구학회(AACR) 정회원
논문 ●
-
Hyeong Ho Jo, Nayoung Kim, Hyeon Jeong Oh, Du Hyun Song, Yonghoon Choi, Jaehyung Park, Jongchan Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn
The Clinicopathological Features of Mixed Carcinoma in 7,215 Patients with Gastric Cancer in a Tertiary Hospital in South Korea.
Gut Liver
2023
-
Hyeong Ho Jo, Nayoung Kim, Hyeon Jeong Oh, Du Hyun Song, Yonghoon Choi, Jaehyung Park, Jongchan Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn
The Clinicopathological Features of Mixed Carcinoma in 7,215 Patients with Gastric Cancer in a Tertiary Hospital in South Korea.
Gut Liver
2022
-
Yonghoon Choi, Nayoung Kim, Ki Wook Kim, Hyeong Ho Jo, Jaehyung Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyeon Jeong Oh, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung-Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim
Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients.
World J Gastroenterol
2022 ;28 (9) :933 -947
-
Ji Yun Lee, Ju-Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang
Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based study.
Thromb Res
2022 ;213 :114 -118
-
Hye Sook Han, Kyoung Eun Lee, Young Ju Suh, Hee-Jung Jee, Bum Jun Kim, Hyeong Su Kim, Keun-Wook Lee, Min-Hee Ryu, Sun Kyung Baek, In Hae Park, Hee Kyung Ahn, Jae Ho Jeong, Min Hwan Kim, Dae Hyung Lee, Siheon Kim, Hyemi Moon, Serim Son, Ji-Hye Byun, Dong Sook Kim, Hyonggin An, Yeon Hee Park, Dae Young Zang
Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.
Ther Adv Med Oncol
2022 ;14 (0) :17588359221132628 -17588359221132628
-
Yu Jung Kim, Seok Joon Yoon, Sang-Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of clinician prediction of survival in oncology outpatients with advanced cancer.
PLoS One
2022 ;17 (4) :e0267467 -e0267467
-
Jin Hyun Park, Mi Young Kim, In Sil Choi, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Jin-Soo Kim
Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.
PLoS One
2022 ;17 (10) :e0276497 -e0276497
-
Minsu Kang, Koung Jin Suh, Ji-Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study.
PLoS One
2022 ;17 (1) :e0261671 -e0261671
-
Funda Meric-Bernstam, Muralidhar Beeram, Erika Hamilton, Do-Youn Oh, Diana L Hanna, Yoon-Koo Kang, Elena Elimova, Jorge Chaves, Rachel Goodwin, Jeeyun Lee, Lisle Nabell, Sun Young Rha, Jose Mayordomo, Anthony El-Khoueiry, Shubham Pant, Kanwal Raghav, Jin Won Kim, Amita Patnaik, Todd Gray, Rupert Davies, Mark A Ozog, Joseph Woolery, Keun-Wook Lee
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
2022 ;23 (12) :1558 -1570
-
Yoon-Koo Kang, Li-Tzong Chen, Min-Hee Ryu, Do-Youn Oh, Sang Cheul Oh, Hyun Cheol Chung, Keun-Wook Lee, Takeshi Omori, Kohei Shitara, Shinichi Sakuramoto, Ik-Joo Chung, Kensei Yamaguchi, Ken Kato, Sun Jin Sym, Shigenori Kadowaki, Kunihiro Tsuji, Jen-Shi Chen, Li-Yuan Bai, Sung-Yong Oh, Yasuhiro Choda, Hisateru Yasui, Kentaro Takeuchi, Yoshinori Hirashima, Shunsuke Hagihara, Narikazu Boku
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
2022 ;23 (2) :234 -247
-
Zev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, Shukui Qin, Kensei Yamaguchi, In-Ho Kim, Anwaar Saeed, Sang Cheul Oh, Jin Li, Haci Mehmet Turk, Alexandra Teixeira, Christophe Borg, Erika Hitre, Adrian A Udrea, Giovanni Gerardo Cardellino, Raquel Guardeno Sanchez, Helen Collins, Siddhartha Mitra, Yingsi Yang, Daniel V T Catenacci, Keun-Wook Lee
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
2022 ;23 (11) :1430 -1440
-
Eun Joo Kang, Yun-Gyoo Lee, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Jii Bum Lee, Jung Hye Kwon, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01).
Korean J Intern Med
2022 ;37 (1) :190 -200
-
Eun Hee Jung, Si Won Lee, Yu Jung Kim, Beodeul Kang, Koung Jin Suh, Ju Hyun Lee, Esther Jeon, Dahee Kim, Sung Soun Hur, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Eduardo Bruera
Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center.
JCO Oncol Pract
2022 ;18 (10) :e1661 -e1671
-
Bum Jun Kim, Hee-Jung Jee, Sun Young Rha, Hye Sook Han, Min-Hee Ryu, Se Hoon Park, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16).
Gastric Cancer
2022 ;25 (3) :609 -618
-
Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Hiroki Sameshima, Li-Tzong Chen, Narikazu Boku
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
2022 ;25 (1) :207 -217
-
D V T Catenacci, Y-K Kang, H H Yoon, B Y Shim, S T Kim, D-Y Oh, A I Spira, S V Ulahannan, E J Avery, P M Boland, J Chao, H C Chung, F Gardner, S J Klempner, K-W Lee, S C Oh, J Peguero, M B Sonbol, L Shen, M Moehler, J Sun, D Li, M K Rosales, H Park
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A.
ESMO Open
2022 ;7 (5) :100563 -100563
-
Minsu Kang, Hee Young Na, Soomin Ahn, Ji-Won Kim, Sejoon Lee, Soyeon Ahn, Ju Hyun Lee, Jeonghwan Youk, Haesook T Kim, Kui-Jin Kim, Koung Jin Suh, Jun Suh Lee, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Yoo-Seok Yoon, Jee Hyun Kim, Jin-Haeng Chung, Ho-Seong Han, Jong Seok Lee
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.
Elife
2022 ;11
-
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily M Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Clin Cancer Res
2022 ;28 (17) :OF1 -OF9
-
Keun-Wook Lee, Eric Van Cutsem, Yung-Jue Bang, Charles S Fuchs, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R Castro, Joseph Chao, Zev A Wainberg, Z Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Razvan Cristescu, Pooja Bhagia, Sukrut Shah, Josep Tabernero, Kohei Shitara, Lucjan Wyrwicz
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study.
Clin Cancer Res
2022 ;28 (16) :3489 -3498
-
Hyun Ae Jung, Keon-Uk Park, Sanghee Cho, Jinyeong Lim, Keun-Wook Lee, Min Hee Hong, Tak Yun, Ho Jung An, Woong-Yang Park, Sergio Pereira, Chan-Young Ock, Bhumsuk Keam
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11).
Clin Cancer Res
2022 ;28 (19) :4240 -4247
-
Jwa Hoon Kim, Changhoon Yoo, Seyoung Seo, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-Pyo Kim, Jung Bok Lee, Keun-Wook Lee, Ji-Won Kim, Il-Hwan Kim, Myoungjoo Kang, Hyewon Ryu, Jaekyung Cheon, Sook Ryun Park
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY.
Cancers (Basel)
2022 ;14 (3)
-
Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01).
Cancer Res Treat
2022 ;54 (1) :109 -117
-
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients.
Cancer Res Treat
2022 ;54 (2) :621 -629
-
Jung Rae Cho, Keun-Wook Lee, Heung-Kwon Oh, Jin Won Kim, Ji-Won Kim, Duck-Woo Kim, Jee Hyun Kim, Sung-Bum Kang
Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer.
Ann Surg Treat Res
2022 ;102 (5) :271 -280
-
So Hyun Kang, Sa-Hong Min, Jin Won Kim, Eunju Lee, Sang Woo Park, Sangjun Lee, Hyeon Jeong Oh, Young Suk Park, Yoon Jin Lee, Ji-Won Kim, Sang-Hoon Ahn, Yun-Suhk Suh, Keun-Wook Lee, Hye Seung Lee, Hyung-Ho Kim
Safety and Efficacy of Intraperitoneal Paclitaxel Plus Intravenous Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) for Gastric Cancer with Peritoneal Metastasis.
Ann Surg Oncol
2022 ;29 (8) :5084 -5091
-
Yusuke Hiratsuka, Yu Jung Kim, Sang-Yeon Suh, Seon Hye Won, Sung Eun Choi, Thomas W LeBlanc, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee
The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer.
Ann Palliat Med
2022 ;11 (7) :2338 -2348
-
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Seon-Hye Won, Eun Hee Jung, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study.
Ann Palliat Med
2022 ;11 (10) :3171 -3180
-
Keun-Wook Lee, Ik-Joo Chung, Min-Hee Ryu, Young Iee Park, Byung-Ho Nam, Ho-Suk Oh, Kyung Hee Lee, Hye Sook Han, Bong-Gun Seo, Jae-Cheol Jo, Hyo Rak Lee, Jin Won Kim, Sook Ryun Park, Sang Hee Cho, Yoon-Koo Kang, SOPP study investigators
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
Gastric Cancer
2021 ;24 (1) :156 -167
-
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience.
Blood Res
2021 ;56 (4) :285 -292
-
Sung-Bum Kang, Jung Rae Cho, Seung-Yong Jeong, Jae Hwan Oh, Soyeon Ahn, Sunkyu Choi, Duck-Woo Kim, Bong Hwa Lee, Eui Gon Youk, Sung Chan Park, Seung Chul Heo, Doo-Seok Lee, Seung-Bum Ryoo, Ji Won Park, Hyoung-Chul Park, Sung-Min Lee, Sung Il Kang, Min Hyun Kim, Heung-Kwon Oh, Rumi Shin, Min Jung Kim, Kyoung Ho Lee, Young-Hoon Kim, Jae-Sung Kim, Keun-Wook Lee, Hye Seung Lee, Hyun Jung Kim, Young Soo Park, Dae Kyung Sohn, Kyu Joo Park, Seoul Colorectal Research Group (SECOG)
Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A long-term prospective, multicentre, cohort study.
Lancet Reg Health West Pac
2021 ;6 :100087 -100087
-
Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy.
J Geriatr Oncol
2021 ;12 (6) :922 -929
-
Yeong Hak Bang, Yong Sang Hong, Ji Sung Lee, Keun-Wook Lee, Hye Sook Han, Sun Young Kim, Ji-Won Kim, Hee Kyung Kim, Jin Won Kim, Choi Ki Eun, Tae Won Kim, Jeong Eun Kim
Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.
Clin Colorectal Cancer
2021 ;20 (2) :101 -112.e6
-
Yun-Gyoo Lee, Hyun Chang, Bhumsuk Keam, Sang Hoon Chun, Jihyun Park, Keon Uk Park, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, Keun-Wook Lee, Hye Ryun Kim, Sung-Bae Kim, Myung-Ju Ahn, In Gyu Hwang
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12.
Cancer Res Treat
2021 ;53 (3) :671 -677
-
Koung Jin Suh, Jin Won Kim, Ji Eun Kim, Ji Hea Sung, Jiwon Koh, Kui-Jin Kim, Ji-Won Kim, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee, Keun-Wook Lee
Correlation between tumor infiltrating immune cells and peripheral regulatory T cell determined using methylation analyses and its prognostic significance in resected gastric cancer.
PLoS One
2021 ;16 (6) :e0252480 -e0252480
-
Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee
Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.
Sci Rep
2021 ;11 (1) :23803 -23803
-
Ji Yun Lee, Minsu Kang, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Kyoung-Ho Song, Eu Suk Kim, Hong Bin Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.
Mycoses
2021 ;64 (1) :60 -65
-
Narikazu Boku, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Taihei Nishiyama, Li-Tzong Chen, Yoon-Koo Kang
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
2021 ;24 (4) :946 -958
-
Ki Wook Kim, Nayoung Kim, Yonghoon Choi, Won Seok Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Young Suk Park, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim
Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
Gastric Cancer
2021 ;24 (4) :844 -857
-
Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).
Ther Adv Med Oncol
2021 ;13 (0) :17588359211042812 -17588359211042812
-
Bum-Sup Jang, Yu Jin Lim, Changhoon Song, Seung Hyuck Jeon, Keun-Wook Lee, Sung-Bum Kang, Yoon Jin Lee, Jae-Sung Kim
Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging.
Radiother Oncol
2021 ;161 :183 -190
-
Eun Joo Kang, Myung-Ju Ahn, Chan-Young Ock, Keun-Wook Lee, Jung Hye Kwon, Yaewon Yang, Yoon Hee Choi, Min Kyoung Kim, Jun Ho Ji, Tak Yun, Byung-Ho Nam, Sung-Bae Kim, Bhumsuk Keam
Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma.
Clin Cancer Res
2021 ;27 (19) :5272 -5279
-
Joel Guigay, Keun-Wook Lee, Manish R Patel, Amaury Daste, Deborah J Wong, Sanjay Goel, Michael S Gordon, Martin Gutierrez, Ani Balmanoukian, Christophe Le Tourneau, Alain Mita, Damien Vansteene, Ulrich Keilholz, Patrick Schoffski, Hans Juergen Grote, Dongli Zhou, Marcis Bajars, Nicolas Penel
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
2021 ;9 (10)
-
Nehal J Lakhani, Laura Q M Chow, Justin F Gainor, Patricia LoRusso, Keun-Wook Lee, Hyun Cheol Chung, Jeeyun Lee, Yung-Jue Bang, Frank Stephen Hodi, Won Seog Kim, Rafael Santana-Davila, Philip Fanning, Pierre Squifflet, Feng Jin, Tracy C Kuo, Hong I Wan, Jaume Pons, Sophia S Randolph, Wells A Messersmith
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lancet Oncol
2021 ;22 (12) :1740 -1751
-
Tae Kyu Chung, Hyun A Lee, Sang-In Park, Do-Youn Oh, Keun-Wook Lee, Jin Won Kim, Jee Hyun Kim, Ahmi Woo, Su Jin Lee, Yung-Jue Bang, Howard Lee
A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors.
Clin Transl Sci
2021 ;14 (3) :990 -1001
-
ApoloAndrea B, EllertonJohn A, InfanteJeffrey R, AgrawalManish, GordonMichael S, AljumailyRaid, GourdinTheodore, DirixLuc, LeeKeun-Wook, TaylorMatthew H, SchoffskiPatrick, WangDing, RavaudAlain, ManitzJuliane, PennockGregory, RuisiMary, GulleyJames L, PatelManish R
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.
J Immunother Cancer
2020 ;8 (2)
-
KimJin Won, ChoSung-Yup, ChaeJeesoo, KimJi-Won, KimTae-Yong, LeeKeun-Wook, OhDo-Youn, BangYung-Jue, ImSeock-Ah
Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer.
Cancer Res Treat
2020 ;52 (4) :1178 -1187
-
ChunYou Jin, KimSeong-Geun, LeeKeun-Wook, ChoSang Hee, KimTae Won, BaekJi Yeon, ParkYoung Suk, HongSoojung, ChuChong Woo, BeomSeung-Hoon, JungMinkyu, ShinSang Joon, AhnJoong Bae
A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Clin Colorectal Cancer
2020 ;19 (3) :e140 -e150
-
Jwa Hoon Kim, Sun Young Kim, Ji Yeon Baek, Yong Jun Cha, Joong Bae Ahn, Han Sang Kim, Keun-Wook Lee, Ji-Won Kim, Tae-You Kim, Won Jin Chang, Joon Oh Park, Jihun Kim, Jeong Eun Kim, Yong Sang Hong, Yeul Hong Kim, Tae Won Kim
A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
Cancer Res Treat
2020 ;52 (4) :1135 -1144
-
ChenLi-Tzong, SatohTaroh, RyuMin-Hee, ChaoYee, KatoKen, ChungHyun Cheol, ChenJen-Shi, MuroKei, KangWon Ki, YehKun-Huei, YoshikawaTakaki, OhSang Cheul, BaiLi-Yuan, TamuraTakao, LeeKeun-Wook, HamamotoYasuo, KimJong Gwang, ChinKeisho, OhDo-Youn, MinashiKeiko, ChoJae Yong, TsudaMasahiro, SameshimaHiroki, KangYoon-Koo, BokuNarikazu
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer
2020 ;23 (3) :510 -519
-
LEE KEUN WOOK, Chung Tae Kyu, Lee Howard, Lee Hyun A, Park Sang-In, Oh Do-Youn, Kim Jin Won, Kim Jee Hyun, Woo Ahmi, Lee Su Jin, Bang Yung-Jue
A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors
CTS-CLIN TRANSL SCI
2020 ;14 (3) :990 -1001
-
Hyun Jung Lee, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells.
Cancers (Basel)
2020 ;12 (9)
-
Kohei Shitara, Eric Van Cutsem, Yung-Jue Bang, Charles Fuchs, Lucjan Wyrwicz, Keun-Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo Raul Castro, Wasat Mansoor, Maria Ignez Braghiroli, Nina Karaseva, Christian Caglevic, Luis Villanueva, Eray Goekkurt, Hironaga Satake, Peter Enzinger, Maria Alsina, Al Benson, Joseph Chao, Andrew H Ko, Zev A Wainberg, Uma Kher, Sukrut Shah, S Peter Kang, Josep Tabernero
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
JAMA Oncol
2020 ;6 (10) :1571 -1580
-
Seung Hyuck Jeon, Changhoon Song, Eui Kyu Chie, Bohyoung Kim, Young Hoon Kim, Won Chang, Yoon Jin Lee, Joo-Hyun Chung, Jin Beom Chung, Keun-Wook Lee, Sung-Bum Kang, Jae-Sung Kim
Combining Radiomics and Blood Test Biomarkers to Predict the Response of Locally Advanced Rectal Cancer to Chemoradiation.
In Vivo
2020 ;34 (5) :2955 -2965
-
Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Jung Hye Kwon, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
BMC Cancer
2020 ;20 (1) :813 -813
-
Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Hark Kyun Kim, Keun-Wook Lee
PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer.
Sci Rep
2020 ;10 (1) :12308 -12308
-
Yoon-Koo Kang, Keisho Chin, Hyun Cheol Chung, Shigenori Kadowaki, Sang Cheul Oh, Norisuke Nakayama, Keun-Wook Lee, Hiroki Hara, Ik-Joo Chung, Masahiro Tsuda, Se Hoon Park, Hisashi Hosaka, Shuichi Hironaka, Yoshinori Miyata, Min-Hee Ryu, Hideo Baba, Ichinosuke Hyodo, Yung-Jue Bang, Narikazu Boku
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
2020 ;21 (8) :1045 -1056
-
Ji Hyun Park, Sang Hoon Chun, Yun-Gyoo Lee, Hyun Chang, Keun-Wook Lee, Hye Ryun Kim, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, In Gyu Hwang, Myung-Ju Ahn, Sung-Bae Kim, Bhumsuk Keam
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12.
J Cancer Res Clin Oncol
2020 ;146 (12) :3359 -3369
-
Daniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, Hope E Uronis, Keun-Wook Lee, Matthew C H Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Johanna C Bendell, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, A Craig Lockhart, Keith L Knutson, Jennifer Yen, Aleksandra Franovic, Jeffrey L Nordstrom, Daner Li, Jon Wigginton, Jan K Davidson-Moncada, Minori Koshiji Rosales, Yung-Jue Bang, CP-MGAH22-5 Study Group
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
2020 ;21 (8) :1066 -1076
-
Hyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, Jang Ho Cho, Jong-Kwon Choi, Keon Uk Park, Eun Joo Kang, Keun-Wook Lee, Sun Min Lim, Jin-Soo Kim, Hyun Woo Lee, Min Kyoung Kim, In Gyu Hwang, Sangwoo Kim, Byung-Ho Nam, Hye Ryun Kim
Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
2020 ;12 (7)
-
Joo Ho Lee, Byung-Hee Kang, Changhoon Song, Sung-Bum Kang, Hye Seung Lee, Keun-Wook Lee, Eui Kyu Chie, Jae-Sung Kim
Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study.
In Vivo
2020 ;34 (4) :2119 -2126
-
Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Dong Ho Lee, Hyung-Ho Kim
Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15?years.
Gastric Cancer
2020 ;23 (6) :1051 -1063
-
Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee
Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases.
J Cancer Res Clin Oncol
2020 ;146 (9) :2399 -2410
-
Byung-Hee Kang, Changhoon Song, Sung-Bum Kang, Keun-Wook Lee, Hye Seung Lee, Jae-Sung Kim
Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
Anticancer Res
2020 ;40 (4) :2171 -2177
-
Grace S Ahn, Hak Ro Kim, Beodeul Kang, Sung Soun Hur, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Yu Jung Kim
Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer center.
Ann Palliat Med
2020 ;9 (2) :216 -223
-
Daniel V T Catenacci, Drew Rasco, Jeeyun Lee, Sun Young Rha, Keun-Wook Lee, Yung Jue Bang, Johanna Bendell, Peter Enzinger, Neyssa Marina, Hong Xiang, Wei Deng, Janine Powers, Zev A Wainberg
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma.
J Clin Oncol
2020 ;38 (21) :2418 -2426
-
Jin Won Kim, Ahrum Min, Seock-Ah Im, Hyemin Jang, Yu Jin Kim, Hee-Jun Kim, Kyung-Hun Lee, Tae-Yong Kim, Keun Wook Lee, Do-Youn Oh, Jee-Hyun Kim, Yung-Jue Bang
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.
Cancers (Basel)
2020 ;12 (2)
-
Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs.
Cancer Res Treat
2020 ;52 (3) :661 -670
-
Ronan J Kelly, Jeeyun Lee, Yung-Jue Bang, Khaldoun Almhanna, Mariela Blum-Murphy, Daniel V T Catenacci, Hyun Cheol Chung, Zev A Wainberg, Michael K Gibson, Keun-Wook Lee, Johanna C Bendell, Crystal S Denlinger, Cheng Ean Chee, Takeshi Omori, Rom Leidner, Heinz-Josef Lenz, Yee Chao, Marlon C Rebelatto, Philip Z Brohawn, Peng He, Jennifer McDevitt, Siddharth Sheth, Judson M Englert, Geoffrey Y Ku
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma.
Clin Cancer Res
2020 ;26 (4) :846 -854
-
Taroh Satoh, Yoon-Koo Kang, Yee Chao, Min-Hee Ryu, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Mitsunobu Tanimoto, Li-Tzong Chen, Narikazu Boku
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
2020 ;23 (1) :143 -153
-
Jang Yeonji, Kim Namju, Lee Keun Wook, Choung Ho Kyung, Khwarg Sang In
Nasolacrimal Duct Stenosis after Oral Capecitabine Administration
KOREAN J OPHTHALMOL
2019 ;33 (1) :95 -96
-
Choe Hun Jee, Kim Jin Won, Lee Hye Seung, Lee Keun-Wook, Han Song-Hee, Lee Ju Hyun, Ahn Sang-Hoon, Park Do Joong, Kim Ji-Won, Kim Yu Jung, Kim Jee Hyun, Kim Hyung-Ho
Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker
CANCERS
2019 ;12 (1)
-
Kwon Ji-Hyun, Lee Jong Seok, Kim Kui-Jin, Sung Ji Hea, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Kim Soyeon, Yoon Sung-Soo
Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement
CELLS-BASEL
2019 ;8 (12)
-
Koh Jiwon, Lee Ho-Young, Lee Hye Seung, Nam Soo Kyung, Lee Youn Woo, Kim Jin Won, Lee Keun-Wook, Ock Chan-Young, Oh Do-Youn, Ahn Sang-Hoon, Kim Hyung-Ho, Kang Keon-Wook, Kim Woo Ho
Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
BIOMOLECULES
2019 ;9 (12)
-
Choi Yeonjoo, Kim Jin Won, Suh Koung Jin, Lim Yoo-Joo, Lee Ji Yun, Kang Beo-Deul, Kim Ji-Won, Kim Se-Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards
BMC PALLIAT CARE
2019 ;18 (1)
-
Hong Yong Sang, Kim Tae Won, Kim Sun Young, Lee Ji Sung, Nam Byung-Ho, Kim Kyu-Pyo, Kim Jeong Eun, Park Young Suk, Park Joon Oh, Baek Ji Yeon, Kim Tae-You, Lee Keun-Wook, Ahn Joong Bae, Lim Seok-Byung, Yu Chang Sik, Kim Jin Cheon, Yun Seong Hyeon, Kim Jong Hoon, Park Jin-Hong, Park Hee Chul, Jung Kyung Hae
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
J CLIN ONCOL
2019 ;37 (33) :3111 -3123
-
Koh Jiwon, Lee Hye Seung, Lee Keun-Wook, Nam Soo Kyung, Seo An Na, Kim Ji-Won, Kim Jin Won, Park Do Joong, Kim Hyung-Ho, Kim Woo Ho
Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications
ONCOLOGIST
2019 ;24 (12) :e1321 -e1330
-
Choe Hun Jee, Lee Ji Yun, Suh Koung Jin, Kim Minyoung, Kim Man Jin, Park Sung Sup, Kim Ji-Won, Kim Se Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report
MEDICINE
2019 ;98 (28)
-
Han Song-Hee, Shin Eun, Kim Jin Won, Kim Milim, Kim Jee Hyun, Lee Keun-Wook, Kim Bo-Hyung, Oh Heung-Kwon, Kim Duck-Woo, Kang Sung-Bum, Kim Hyunchul
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy
ONCOL LETT
2019 ;17 (6) :5572 -5580
-
Oh Do-Youn, Lee Keun-Wook, Han Sae-Won, Kim Jin Won, Shin Jung-Won, Jo Seong-Jin, Won Jonghwa, Hahn Seokyung, Lee Howard, Kim Woo Ho, Bang Yung-Jue
A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors
ONCOLOGIST
2019 ;24 (8) :1037 -e636
-
Yoo Shin Hye, Keam Bhumsuk, Ock Chan-Young, Kim Sehui, Han Buhm, Kim Ji-Won, Lee Keun-Wook, Jeon Yoon Kyung, Jung Kyeong Cheon, Chung Eun-Jae, Kwon Seong Keun, Ahn Soon-Hyun, Sung Myung-Whun, Heo Dae Seog
Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
SCI REP-UK
2019 ;9 (1)
-
Bang Yung-Jue, Kim Tae-Yong, Han Hye Sook, Lee Keun-Wook, Zang Dae Young, Rha Sun Young, Park Young Iee, Kim Jin-Soo, Lee Kyung-Hun, Park Se Hoon, Song Eun-Kee, Jung Soo-A, Lee NaMi, Kim Yeul Hong, Cho Jae Yong
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
GASTRIC CANCER
2019 ;22 (6) :1206 -1214
-
Jeon Seung Hyuck, Song Changhoon, Chie Eui Kyu, Kim Bohyoung, Kim Young Hoon, Chang Won, Lee Yoon Jin, Chung Joo-Hyun, Chung Jin Beom, Lee Keun-Wook, Kang Sung-Bum, Kim Jae-Sung
Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer
RADIAT ONCOL
2019 ;14 (1)
-
Han Jae Joon, Kim Jin Won, Suh Koung Jin, Kim Ji-Won, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun, Lee Jong Seok, Lee Keun-Wook
Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer
ASIA-PAC J CLIN ONCO
2019 ;15 (3) :158 -165
-
Keam Bhumsuk, Lee Keun-Wook, Lee Se-Hoon, Kim Jin-Soo, Kim Jin Ho, Wu Hong-Gyun, Eom Keun-Yong, Kim Suzy, Ahn Soon-Hyun, Chung Eun-Jae, Kwon Seong Keun, Jeong Woo-Jin, Jung Young Ho, Kim Ji-Won, Heo Dae Seog
A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
ONCOLOGIST
2019 ;24 (6) :751 -e231
-
Chung Eun-Jae, Ahn Soon-Hyun, Rho Young-Soo, Jeong Woo-Jin, Jung Young Ho, Kwon Seong Keun, Kwon Tack-Kyun, Sung Myung-Whun, Keam Bhumsuk, Heo Dae-Seog, Kim Jin Ho, Wu Hong-Gyun, Lee Keun-Wook, Eom Keun-Yong
Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases
ORAL ONCOL
2019 ;89 :84 -94
-
Chung Hyun Cheol, Arkenau Hendrik-Tobias, Lee Jeeyun, Rha Sun Young, Oh Do-Youn, Wyrwicz Lucjan, Kang Yoon-Koo, Lee Keun-Wook, Infante Jeffrey R, Lee Sung Sook, Kemeny Margaret, Keilholz Ulrich, Melichar Bohuslav, Mita Alain, Plummer Ruth, Smith Denis, Gelb Arnold B, Xiong Huiling, Hong Janet, Chand Vikram, Safran Howard
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
J IMMUNOTHER CANCER
2019 ;7 (1)
-
Keilholz Ulrich, Mehnert Janice M, Bauer Sebastian, Bourgeois Hugues, Patel Manish R, Gravenor Donald, Nemunaitis John J, Taylor Matthew H, Wyrwicz Lucjan, Lee Keun-Wook, Kasturi Vijay, Chin Kevin, von Heydebreck Anja, Gulley James L
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
J IMMUNOTHER CANCER
2019 ;7 (1)
-
Kim Jin Won, Kim Jong Gwang, Kang Byung Woog, Chung Ik-Joo, Hong Young Seon, Kim Tae-You, Song Hong Suk, Lee Kyung Hee, Zang Dae Young, Ko Yoon Ho, Song Eun-Kee, Baek Jin Ho, Koo Dong-Hoe, Oh So Yeon, Cho Hana, Lee Keun-Wook
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
CANCER RES TREAT
2019 ;51 (1) :223 -239
-
Kang Y-K, Boku N, Ryu M-H, Kato K, Chung H C, Minashi K, Lee K-W, Cho H, Kang W K, Komatsu Y, Tsuda M, Yamaguchi K, Hara H, Fumita S, Azuma M, Chen L-T
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
ANN ONCOL
2019 ;30 (2) :250 -258
-
Shin Junghoon, Kim Se Hyun, Chung Jin-Haeng, Lee Kyu Sang, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin-Won, Kim Yu-Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong-Seok
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
CANCER RES TREAT
2019 ;51 (3) :1086 -1097
-
Lee Jeong-Ok, Bang Soo-Mee, Lee Ji Yun, Chun Eun Ju, Choi Sang Il, Kim Jin Won, Kim Se Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Lee Jong Seok
Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study
SUPPORT CARE CANCER
2019 ;27 (7) :2507 -2515
-
Moehler Markus, Ryu Min-Hee, Dvorkin Mikhail, Lee Keun-Wook, Co?kun Hasan ?, Wong Rachel, Chung Hyun C, Poltoratsky Artem, Tsuji Akihito, Yen Chia Jui, Muntean Alina S, Le Sourd Samuel, Vaccaro Gina M, Overton Lindsay, Boku Narikazu, Wainberg Zev A, Patel Manish, Sharma Maitreyi, Xiong Huiling, Conti Ilaria, Taieb Julien, Bang Yung-Jue
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
FUTURE ONCOL
2019 ;15 (6) :567 -577
-
Lee Keun-Wook, Cho Jae Yong, Maeng Chi Hoon, Kim Tae-You, Zang Dae Young, Kim Yeul Hong, Hwang In Gyu, Oh Sang Cheul, Chung Joo Seop, Song Hong Suk, Kim Jin Won, Jeong Su Jin
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)
ONCOLOGIST
2019 ;24 (1) :18 -e24
-
Son I T, Lee H S, Ihn M H, Lee K H, Kim D-W, Lee K-W, Kim J-S, Kang S-B
Isolation of internal and external sphincter progenitor cells from the human anal sphincter with or without radiotherapy
COLORECTAL DIS
2019 ;21 (1) :38 -47
-
Yhim Ho-Young, Bang Soo-Mee, Choi Won-Il, Kim Sung-Hyun, Nam Seung-Hyun, Kim Kyoung Ha, Mun Yeung-Chul, Oh Doyeun, Hwang Hun-Gyu, Lee Keun-Wook, Song Eun-Kee, Kwon Yong Shik
Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
KOREAN J INTERN MED
2019 ;34 (5) :1125 -1135
-
Lim Sun Min, Yun Hwan Jung, Cho Sang Hee, Hwang In Gyu, Choi Jae Woo, Chang Hyun, Ahn Myung-Ju, Park Keon Uk, Kim Ji-Won, Ko Yoon Ho, Ahn Hee Kyung, Cho Byoung Chul, Nam Byung-Ho, Chun Sang Hoon, Hong Ji Hyung, Kwon Jung Hye, Choi Jong Gwon, Kang Eun Joo, Yun Tak, Lee Keun-Wook, Kim Joo-Hang, Kim Jin Soo, Lee Hyun Woo, Kim Min Kyoung, Jung Dongmin, Kim Ji Eun, Keam Bhumsuk, Kim Sangwoo, Kim Hye Ryun
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
CANCER RES TREAT
2019 ;51 (1) :300 -312
-
Lee Yun-Gyoo, Kim Inho, Oh Somi, Shin Dong-Yeop, Koh Youngil, Lee Keun-Wook
Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia
KOREAN J INTERN MED
2019 ;34 (1) :178 -183
-
Lee Joo Ho, Song Changhoon, Kang Sung-Bum, Lee Hye Seung, Lee Keun-Wook, Kim Jae-Sung
Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
ANTICANCER RES
2018 ;38 (12) :6905 -6910
-
Choi In Sil, Kim Jee Hyun, Lee Ju Hyun, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se-Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Bang Soo-Mee, Lee Jong Seok, Lee Keun-Wook
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
PLOS ONE
2018 ;13 (10)
-
Kim Se Hyun, Ryu Haram, Ock Chan-Young, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Bang Soo-Mee, Kim Jee Hyun, Lee Jong Seok, Ahn Joong Bae, Kim Kui-Jin, Rha Sun Young
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
INT J MOL SCI
2018 ;19 (10)
-
Song Changhoon, Chung Joo-Hyun, Kang Sung-Bum, Kim Duck-Woo, Oh Heung-Kwon, Lee Hye Seung, Kim Jin Won, Lee Keun-Wook, Kim Jee Hyun, Kim Jae-Sung
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
CANCERS
2018 ;10 (9)
-
Yen Chia-Jui, Muro Kei, Kim Tae-Won, Kudo Masatoshi, Shih Jin-Yuan, Lee Keun-Wook, Chao Yee, Kim Sang-We, Yamazaki Kentaro, Sohn JooHyuk, Cheng Rebecca, Zhang Yawei, Binder Polina, Mi Gu, Orlando Mauro, Chung Hyun Cheol
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
J Glob Oncol
2018 ;4 :1 -12
-
Bang Y-J, Ruiz E Yanez, Van Cutsem E, Lee K-W, Wyrwicz L, Schenker M, Alsina M, Ryu M-H, Chung H-C, Evesque L, Al-Batran S-E, Park S H, Lichinitser M, Boku N, Moehler M H, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
ANN ONCOL
2018 ;29 (10) :2052 -2060
-
Kim Sun Young, Joo Jungnam, Kim Tae Won, Hong Yong Sang, Kim Jeong Eun, Hwang In Gyu, Kim Beom Gyu, Lee Keun-Wook, Kim Ji-Won, Oh Ho-Suk, Ahn Joong Bae, Zang Dae Young, Kim Dae Yong, Oh Jae Hwan, Baek Ji Yeon
A Randomized Phase 2 Trial of Consolidation Chemotherapy After Preoperative Chemoradiation Therapy Versus Chemoradiation Therapy Alone for Locally Advanced Rectal Cancer: KCSG CO 14-03
INT J RADIAT ONCOL
2018 ;101 (4) :889 -899
-
Choi In Sil, Choi Mihong, Lee Ju Hyun, Kim Jee Hyun, Suh Koung Jin, Lee Ji Yun, Kang Beodeul, Kim Ji-Won, Kim Se-Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Bang Soo-Mee, Lee Jong Seok, Lee Keun-Wook
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
PLOS ONE
2018 ;13 (6)
-
Lee Yoontaek, Min Sa-Hong, Park Ki Bum, Park Young Suk, Kim Ji-Won, Ahn Sang-Hoon, Kim Jin Won, Park Do Joong, Lee Keun-Wook, Kim Hyung-Ho
Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis
J GASTRIC CANCER
2018 ;18 (1) :58 -68
-
Xu Rui-Hua, Muro Kei, Morita Satoshi, Iwasa Satoru, Han Sae Won, Wang Wei, Kotaka Masahito, Nakamura Masato, Ahn Joong Bae, Deng Yan-Hong, Kato Takeshi, Cho Sang-Hee, Ba Yi, Matsuoka Hiroshi, Lee Keun-Wook, Zhang Tao, Yamada Yasuhide, Sakamoto Junichi, Park Young Suk, Kim Tae Won
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
LANCET ONCOL
2018 ;19 (5) :660 -671
-
Jung Minkyu, Ryu Min-Hee, Oh Do Youn, Kang Myounghee, Zang Dae Young, Hwang In Gyu, Lee Keun-Wook, Kim Ki Hyang, Shim Byoung Yong, Song Eun Kee, Sym Sun Jin, Han Hye Sook, Park Young Lee, Kim Jin Soo, Lee Hyun Woo, Lee Moon Hee, Koo Dong-Hoe, Song Hong Suk, Lee Namsu, Yang Sung Hyun, Choi Dae Ro, Hong Young Seon, Lee Kyoung Eun, Maeng Chi Hoon, Baek Jin Ho, Kim Samyong, Kim Yeul Hong, Rha Sun Young, Cho Jae Yong, Kang Yoon-Koo
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)
GASTRIC CANCER
2018 ;21 (5) :819 -830
-
Patel Manish R, Ellerton John, Infante Jeffrey R, Agrawal Manish, Gordon Michael, Aljumaily Raid, Britten Carolyn D, Dirix Luc, Lee Keun-Wook, Taylor Mathew, Schoffski Patrick, Wang Ding, Ravaud Alain, Gelb Arnold B, Xiong Junyuan, Rosen Galit, Gulley James L, Apolo Andrea B
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
LANCET ONCOL
2018 ;19 (1) :51 -64
-
Lee Keun-Wook, Lee Dae Ho, Kang Jin Hyoung, Park Joon Oh, Kim Se Hyun, Hong Yong Sang, Kim Seung Tae, Oh Do-Youn, Bang Yung-Jue
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors
ONCOLOGIST
2018 ;23 (2) :155 -e17
-
Kim Tae Min, Lee Keun-Wook, Oh Do-Youn, Lee Jong-Seok, Im Seock-Ah, Kim Dong-Wan, Han Sae-Won, Kim Yu Jung, Kim Tae-You, Kim Jee Hyun, Han Hyesun, Kim Woo Ho, Bang Yung-Jue
Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
CANCER RES TREAT
2018 ;50 (3) :835 -842
-
Kim Namju, Kim Jin Won, Baek Je-Hyun, Kim Jin-Soo, Choung Ho-Kyung, Kim Tae-Yong, Lee Kyung-Hun, Bang Yung-Jue, Khwarg Sang In, Ahn Sang-Hoon, Park Do Joong, Kim Hyung-Ho, Chung Jae-Yong, Ahn Soyeon, Lee Keun-Wook
S-1-Induced Lacrimal Drainage Obstruction and Its Association with Ingredients/Metabolites of S-1 in Tears and Plasma: A Prospective Multi-institutional Study
CANCER RES TREAT
2018 ;50 (1) :30 -39
-
Choi In Sil, Lee Keun-Wook, Zang Dae Young, Ryu Min-Hee, Kim Ki Hyang, Kim Mi-Jung, Han Hye Sook, Koh Sung Ae, Park Jin Hyun, Kim Jin Won, Nam Byung-Ho
Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial
Contemp Clin Trials Commun
2017 ;8 :55 -61
-
Kim Ji-Won, Lee Hye Seung, Nam Kyung Han, Ahn Soyeon, Kim Jin Won, Ahn Sang-Hoon, Park Do Joong, Kim Hyung-Ho, Lee Keun-Wook
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
Oncotarget
2017 ;8 (53) :90948 -90958
-
Bang Yung-Jue, Boku Narikazu, Chin Keisho, Hodgson Darren, Im Seock-Ah, Lee Keun-Wook, Liu Yu-Zhen, Locker Gershon, Park Se Hoon, Qin Shukui, Rha Sun Young, Rowe Phil, Shen Lin, Shi Xiaojin, Xu Nong, Xu Rui-Hua
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
LANCET ONCOL
2017 ;18 (12) :1637 -1651
-
Ock Chan-Young, Jang Hee-Jin, Hwang Jun-Eul, Keam Bhumsuk, Kim Sang-Bae, Shim Jae-Jun, Park Sarang, Sohn Bo Hwa, Cha Minse, Ajani Jaffer A, Kopetz Scott, Lee Keun-Wook, Kim Tae Min, Heo Dae Seog, Lee Ju-Seog
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
NAT COMMUN
2017 ;8 (1)
-
Kim Se Hyun, Kim Mi-Jung, Lee Jong Seok, Kim Yu Jung, Chang Hyun, Kim Jin Won, Lee Jeong-Ok, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee
Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
MEDICINE
2017 ;96 (42)
-
Kang Yoon-Koo, Boku Narikazu, Satoh Taroh, Ryu Min-Hee, Chao Yee, Kato Ken, Chung Hyun Cheol, Chen Jen-Shi, Muro Kei, Kang Won Ki, Yeh Kun-Huei, Yoshikawa Takaki, Oh Sang Cheul, Bai Li-Yuan, Tamura Takao, Lee Keun-Wook, Hamamoto Yasuo, Kim Jong Gwang, Chin Keisho, Oh Do-Youn, Minashi Keiko, Cho Jae Yong, Tsuda Masahiro, Chen Li-Tzong
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
LANCET
2017 ;390 (10111) :2461 -2471
-
Suh Koung Jin, Sung Ji Hea, Kim Jin Won, Han Song-Hee, Lee Hye Seung, Min Ahrum, Kang Mi Hyun, Kim Ji Eun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Im Seock-Ah, Lee Jong Seok
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
Oncotarget
2017 ;8 (38) :63901 -63910
-
Kim Jin Won, Kim Haeryoung, Park Sehhoon, Kim Ji-Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Kim Jai Hwan, Hwang Jin-Hyeok, Choi Young Rok, Cho Jai Young, Yoon Yoo-Seok, Han Ho-Seong
Prognostic value of p21-activated kinase 4 in resected pancreatic cancer
APMIS
2017 ;125 (8) :699 -707
-
Lee Ji Yun, Bang Soo-Mee, Lee Ju-Hyun, Lee Heeyoung, Kang Beodeul, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Choi Hyoung Soo, Lee Jong Seok
Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea
THROMB RES
2017 ;155 :86 -91
-
Son Il Tae, Kim Young Hoon, Lee Kyoung Ho, Kang Sung Il, Kim Duck-Woo, Shin Eun, Lee Keun-Wook, Ahn Soyeon, Kim Jae-Sung, Kang Sung-Bum
Oncologic relevance of magnetic resonance imaging-detected threatened mesorectal fascia for patients with mid or low rectal cancer: A longitudinal analysis before and after long-course, concurrent chemoradiotherapy
SURGERY
2017 ;162 (1) :152 -163
-
Kim Ji-Won, Lee Keun-Wook, Kim Kyu-Pyo, Lee Ju Hyun, Hong Yong Sang, Kim Jeong-Eun, Kim Sun Young, Park Sook Ryun, Nam Byung-Ho, Cho Sang-Hee, Chung Ik-Joo, Park Young Suk, Oh Ho-Suk, Lee Myung-Ah, Kang Hye Jin, Park Young Iee, Song Eun-Kee, Han Hye Sook, Lee Kyu Taeg, Shin Dong Bok, Kang Jung Hun, Zang Dae Young, Kim Jee Hyun, Kim Tae Won
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer
ONCOLOGIST
2017 ;22 (3) :293 -303
-
Yoo Shin Hye, Kim Se Hyun, Kim Hyean-Ji, Kim Jeong-Han, Lee Gyeong-Won, Lee Jeong Hee, Kim Ji-Won, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok
Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy
MEDICINE
2017 ;96 (1)
-
Lee Keun-Wook, Kim Bum Jun, Kim Mi-Jung, Han Hye Sook, Kim Jin Won, Park Young Iee, Park Sook Ryun
A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
CANCER RES TREAT
2017 ;49 (3) :706 -716
-
Choi Yeonjoo, Kim Jin Won, Nam Kyung Han, Han Song-Hee, Kim Ji-Won, Ahn Sang-Hoon, Park Do Joong, Lee Keun-Wook, Lee Hye Seung, Kim Hyung-Ho
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
GASTRIC CANCER
2017 ;20 (4) :602 -611
-
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
CHIN J CANCER
2016 ;35 (1)
-
Preoperative chemoradiotherapy for elderly patients with locally advanced rectal cancer-a real-world outcome study
JPN J CLIN ONCOL
2016 ;46 (12) :1108 -1117
-
Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
CLIN CANCER RES
2016 ;22 (24) :6228 -6235
-
Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
CL LYMPH MYELOM LEUK
2016 ;16 (9) :503 -510.e3
-
Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer
J CANCER RES CLIN
2016 ;142 (3) :687 -697
-
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
J GASTROEN HEPATOL
2016 ;31 (3) :581 -589
-
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer
GASTRIC CANCER
2016 ;19 (1) :42 -52
-
Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
CANCER RES TREAT
2016 ;48 (3) :978 -989
-
Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
GASTRIC CANCER
2016 ;19 (4) :1095 -1103
-
Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment (18)FFDG PET/CT scans in locally advanced rectal cancer
EUR J NUCL MED MOL I
2016 ;43 (3) :422 -431
-
Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells
CANCER RES TREAT
2016 ;48 (1) :355 -364
-
Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors
CANCER RES TREAT
2016 ;48 (1) :28 -36
-
Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment
ANTICANCER RES
2015 ;35 (10) :5631 -5638
-
A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7
PLOS ONE
2015 ;10 (9)
-
Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
PLOS ONE
2015 ;10 (9)
-
A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer
ONCOLOGIST
2015 ;20 (10) :1119 -1120
-
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
J CLIN ONCOL
2015 ;33 (33) :3858 -3865
-
Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer
ONCOLOGIST
2015 ;20 (8) :896 -897
-
Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial
TRIALS
2015 ;16
-
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
CANCER-AM CANCER SOC
2015 ;121 (15) :2612 -2617
-
Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis
PLOS ONE
2015 ;10 (4)
-
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
CANCER CHEMOTH PHARM
2015 ;75 (6) :1175 -1182
-
Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer
PLOS ONE
2015 ;10 (3)
-
Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden
THROMB RES
2015 ;135 (5) :846 -851
-
Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer
CLIN CANCER RES
2015 ;21 (11) :2520 -2529
-
Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer
CANCER RES TREAT
2015 ;47 (4) :687 -696
-
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
CANCER RES TREAT
2015 ;47 (4) :670 -675
-
p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
CANCER RES TREAT
2015 ;47 (3) :501 -508
-
Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging
ANN SURG ONCOL
2015 ;22 (7) :2159 -2167
-
Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients
CLIN CANCER RES
2015 ;21 (2) :357 -364
-
Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells
ONCOL REP
2015 ;33 (1) :185 -192
-
Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort
CANCER RES TREAT
2015 ;47 (2) :215 -220
-
Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
SUPPORT CARE CANCER
2015 ;23 (3) :687 -694
-
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
GASTRIC CANCER
2015 ;18 (3) :476 -484
-
Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients
MED ONCOL
2014 ;31 (3)
-
The early discontinuation of palliative chemotherapy in older patients with cancer
SUPPORT CARE CANCER
2014 ;22 (3) :773 -781
-
Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma
TUMORI
2014 ;100 (4) :439 -445
-
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
BMC CANCER
2014 ;14
-
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer
THROMB HAEMOSTASIS
2014 ;111 (6) :1112 -1120
-
Prevalence and risk factors for iron deficiency anemia in the korean population: results of the fifth KoreaNational Health and Nutrition Examination Survey
J KOREAN MED SCI
2014 ;29 (2) :224 -229
-
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis
J CANCER RES CLIN
2014 ;140 (9) :1567 -1574
-
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
CANCER CHEMOTH PHARM
2014 ;74 (3) :447 -455
-
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer
BMC CANCER
2014 ;14
-
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy
BREAST CANCER-TOKYO
2014 ;21 (4) :387 -393
-
Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis
EUR J CANCER
2014 ;50 (16) :2810 -2821
-
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival
GASTRIC CANCER
2013 ;16 (4) :581 -589
-
Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA)
ANN HEMATOL
2013 ;92 (1) :59 -65
-
Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer
CANCER SCI
2013 ;104 (1) :116 -123
-
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy
INVEST NEW DRUG
2013 ;31 (1) :183 -191
-
Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea
JPN J CLIN ONCOL
2013 ;43 (2) :132 -138
-
The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE
THROMB RES
2013 ;131 (4) :e133 -e140
-
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
CANCER CHEMOTH PHARM
2013 ;71 (4) :843 -851
-
A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients
PLOS ONE
2013 ;8 (4)
-
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
INVEST NEW DRUG
2013 ;31 (6) :1547 -1558
-
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis
ANN ONCOL
2013 ;24 (11) :2850 -2854
-
Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans
ASIAN PAC J CANCER P
2012 ;13 (4) :1209 -1215
-
Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment
J GYNECOL ONCOL
2012 ;3 (4) :359 -367
-
Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
BMC CANCER
2012 ;12
-
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
LUNG CANCER
2012 ;76 (3) :387 -392
-
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
INVEST NEW DRUG
2012 ;30 (3) :1164 -1174
-
Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas
CANCER-AM CANCER SOC
2012 ;118 (24) :6162 -6170
-
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
LANCET ONCOL
2012 ;13 (11) :1125 -1132
-
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
LANCET
2012 ;379 (9813) :315 -321
-
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
BMC CANCER
2012 ;12 (1) :1 -10
-
Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy
ANN ONCOL
2012 ;23 (8) :2065 -2071
-
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer
ANN ONCOL
2012 ;23 (4) :911 -918
-
Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.
Korean J Intern Med
2011 ;26 (1) :82 -88
-
Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population
AM J HEMATOL
2011 ;86 (9) :752 -755
-
The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer.
DIS COLON RECTUM
2011 ;54 (2) :245 -252
-
Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy
J CANCER RES CLIN
2011 ;137 (5) :839 -847
-
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy.
JPN J CLIN ONCOL
2011 ;41 (3) :430 -433
-
Metastatic Adrenocortical Carcinoma Presenting Simultaneously with Cushing's and Conn's Syndromes: A Case Report
JPN J CLIN ONCOL
2011 ;41 (11) :1287 -1291
-
Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy
GASTRIC CANCER
2011 :1 -9
-
Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.
THROMB HAEMOSTASIS
2011 ;106 (6) :1084 -1094
-
Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes.
MED ONCOL
2011 ;28 (4) :991 -998
-
Anaplastic thyroid carcinoma initially presented with abdominal cutaneous mass and hyperthyroidism.
Korean J Intern Med
2010 ;25 (4) :450 -453
-
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era.
Cancer Res Treat
2010 ;42 (4) :203 -209
-
Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab.
Korean J Intern Med
2010 ;25 (1) :86 -93
-
Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.
J KOREAN MED SCI
2010 ;25 (5) :684 -90
-
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less.
BMC CANCER
2010 :557
-
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
CANCER SCI
2010 ;101 (3) :793 -799
-
Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer
MED ONCOL
2010 ;27 (3) :992 -997
-
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer
J THROMB HAEMOST
2010 ;8 :540 -547
-
Prognostic Significance of Pre-operative FDG-PET in Colorectal Cancer
Nucl Med Mol Imaging
2009 ;43 (5) :429 -435
-
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
ANN HEMATOL
2009 ;88 (0) :829 -838
-
Metastatic adrenocortical carcinoma treated with sunitinib: a case report.
JPN J CLIN ONCOL
2009 ;39 (3) :183 -185
-
Efficacy and Toxicity of Pemetrexed as a Third-line Treatment for Non-small Cell Lung Cancer.
JPN J CLIN ONCOL
2009 ;39 (1) :27 -32
-
Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: megnitude of HeR2/neu amplification as a predictive factor for efficacy.
J Korean Med 1
2009
-
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.
ANN ONCOL
2009
-
Weight changes after adjuvant treatment in Korean women with early breast cancer.
BREAST CANCER RES
2009
-
Phase Ⅱ study and biomaker analysis of cetuximab combined with codified FOLFOX6 in advanced gastric cancer.
BRIT J CANCER
2009
저서 및 특허 ●
- 2015 The Essentials of Head & Neck Oncology (Oral Cavity Cancer)
- 2011 대장암 예방과 치료 그리고 극복
| 번호 | 매체명 | 제목 | 발간일 |
|---|---|---|---|
| 137 | 데일리팜 | 심평원 암질심 10기 활동 시작…내일 2차 회의 참여
|
2024-03-05 |
| 136 | 디지틀조선일보 | 전이성·재발성 위암 표준 치료제 ‘복합항암제’, 고령 환자도 효과 확인
|
2023-12-23 |
| 135 | 분당서울대병원 블로그 | 분당서울대병원 임상시험센터 확장개소로 병원 연구 기능 강화
|
2023-12-21 |
| 134 | 아시아경제 | 젊은층에 주로 쓰던 복합항암제, 고령 위암 환자에도 효과
|
2023-12-18 |
| 133 | 세계일보 | 70대 이상 고령의 전이·재발성 위암 환자, 복합 항암제 생존 기간 향상에 도...
|
2023-12-16 |
| 132 | 이투데이 | 70세 이상 고령 위암 환자도 ‘복합항암제’ 효과적
|
2023-12-14 |
| 131 | 한국일보 | 고령 전이·재발 위암, '복합 항암화학요법' 효과
|
2023-12-14 |
| 130 | 이데일리 | 전이성. 재발성 고령 위암 환자 대상 복합항암제 사용 효과 입증
|
2023-12-14 |
| 129 | 경기일보 | 분당서울대병원, 연구 역량 강화한다… 임상시험센터 확장 개소
|
2023-07-17 |
| 128 | 아주경제 | 분당서울대, 헬스케어혁신파크 임상시험센터 개소
|
2023-07-16 |
-
대표전화 : 1588-3369
-
-
Copyright © 분당서울대학교병원. All Rights Reserved.
-
-
BSI ISO27001
인증번호 : IS 679936
유효기간 : 2023.09.15 ~ 2025.10.30 -
BSI ISO27799
인증번호 : PHIS 731156
유효기간 : 2023.09.15 ~ 2025.10.30 -
BSI ISO27701
인증번호 : PM 789919
유효기간 : 2023.07.17 ~ 2026.07.16 -
ISMS 인증
인증범위 : 의료정보시스템(OCS,EMR 및 홈페이지 서비스 운영)
유효기간 : 2021.01.06 ~ 2024.01.05
-
웹접근성 인증
과학기술정보통신부
WEB ACCESSIBILITY -
EMR 7단계 인증
미국외 세계최초
EMR 7단계 인증(2010년) -
보건복지부 의료기관 인증
보건복지부
의료기관 인증
-
BSI ISO27001
인증번호 : IS 679936
